Quarterly Result5 May 2025, 03:22 pm
Epigral Ltd Reports 13% Rise in Q4FY25 PAT to Rs 87 Crore, Proposes Final Dividend of Rs 3.5 Per Share
AI Summary
Epigral Ltd, a leading integrated chemical manufacturer, announced its financial results for the quarter ended March 31, 2025. The company posted a 13% rise in PAT at Rs 87 crore for Q4FY25. Total revenue stood at Rs 631 crore, a jump of 20% compared to Q4FY24. The company's balance sheet got further strengthened in FY2025 with ROCE at 25% and Net Debt/EBITDA at 0.7x. Epigral's board proposed a final dividend of Rs 3.5 per share, taking the total dividend for FY2025 to Rs 6 per share.
Key Highlights
- Epigral's Q4FY25 PAT up 13% to Rs 87 Crore
- Total Dividend for FY2025 aggregate to Rs 6 per equity share (60% of FV Rs 10)
- Epigral's credit rating upgraded to Crisil AA from Crisil AA-
- Epigral spent Rs 195 Crore on capex in FY2025
- Epigral’s board has approved doubling its CPVC Resin and Epichlorohydrin (ECH) Capacity